INJURY-INDUCES PAIN-- CHEMICAL MODULATION OF NOCICEPTORS
INJURY-INDUCES PAIN-- CHEMICAL MODULATION OF NOCICEPTORS
批准号:
6393422
负责人:
SRINIVASA N. RAJA
金额:
$32.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-04-01 至 2005-04-30
关键词:
alpha adrenergic receptor antiadrenergic agents behavioral /social science research tag biological models clinical research dorsal horn electrophysiology human subject hyperalgesia laboratory mouse laboratory rat mechanoreceptors molecular psychobiology nerve injury neuropeptide receptor neuropharmacology neurophysiology neurotrophic factors nociceptors norepinephrine opioid receptor pain psychophysiology skin sympathetic nervous system
中文摘要
神经病理性疼痛的机制仍然不完全清楚。 这项资助将研究周围神经损伤后周围神经和中枢神经系统发生的变化。 神经性疼痛患者的心理物理学研究将通过明确的神经性疼痛模型中的行为和电生理学研究来补充,该模型涉及大鼠L5脊神经的结扎,以及特定蛋白质的小鼠突变体。 前两个具体目标集中在肾上腺素能敏感性,在皮肤中的一个子集的神经性疼痛,维持交感神经传出纤维的活动(交感神经维持疼痛,SMP)的患者。 在先前的研究期间,发现去甲肾上腺素皮内注射可使SMP患者产生剂量依赖性疼痛,这表明皮肤伤害感受器在这种疾病中对肾上腺素产生敏感性。 在即将到来的资助期间,去甲肾上腺素离子电渗疗法在有和没有SMP的患者中将作为一种新的、非侵入性的SMP诊断测试进行测试(Sp. Aim 1)。 此外,将通过测量选择性肾上腺素能激动剂和拮抗剂的皮肤离子电渗疗法后疼痛的变化来研究SMP的肾上腺素受体药理学(Sp. Aim 2)。 神经性疼痛的患者特别痛苦的疼痛诱发正常无害的机械刺激。 一系列的实验将集中于确定伤害性传入纤维和低阈值机械感受器(LTM)在神经病理性动物痛觉过敏信号传导中的不同作用。 将使用神经毒素辣椒素(Sp. Aim 3)研究伤害感受器功能选择性丧失的影响,并将使用特定神经营养因子的小鼠突变体(Sp. Aim 4)检查LTM的选择性耗竭。 最后两个具体目标集中在神经损伤后脊髓背角兴奋性增加的机制上。 这种背角敏化可能是由于兴奋机制的增加或抑制机制的减少。在即将到来的资助期内,将通过研究神经激肽(NK)受体系统对脊髓伤害性传递的调节作用来探索兴奋机制的变化(Sp. Aim 5)。 将通过研究阿片受体系统的调节作用来探索抑制机制的变化(Sp. Aim 6)。 使用选择性NK拮抗剂的药理学和神经生理学研究将用于确定NK受体在神经性疼痛中是否上调。 此外,将在NK-1受体和μ-阿片受体敲除小鼠中检查疼痛行为和背角生理学。 这些研究的结果将为神经病理性疼痛的外周和中枢机制提供新的见解,并可能导致新的诊断和治疗策略。
英文摘要
The mechanisms underlying neuropathic pain remain incompletely understood. This grant will examine changes that occur in both the peripheral and central nervous system after a peripheral nerve injury. Psychophysical studies in patients with neuropathic pain will be complemented by behavioral and electrophysiological studies in a well-defined model of neuropathic pain that involves ligation of the L5 spinal nerve in rats, and in mice mutant for specific proteins. The first two specific aims focus on the adrenergic sensitivity that develops in the skin of a subset of patients with neuropathic pain that is maintained by activity in sympathetic efferent fibers (sympathetically maintained pain, SMP). During the previous grant period, intradermal injections of norepinephrine were found to produce a dose-dependent pain in patients with SMP, suggesting that cutaneous nociceptors develop a sensitivity to adrenaline in this disease. During the coming grant period, norepinephrine iontophoresis in patients with and without SMP will be tested as a new, non-invasive, diagnostic test for SMP (Sp. Aim 1). In addition, the adrenoceptor pharmacology of SMP will be investigated by measuring the alterations in pain following the cutaneous iontophoresis of selective adrenergic agonists and antagonists (Sp. Aim 2). Patients with neuropathic pain are particularly distressed by the pain evoked by normally innocuous mechanical stimuli. A series of experiments will focus on determining the differential role of nociceptive afferent fibers and low-threshold mechanoreceptors (LTMs) in signaling the hyperalgesia in neuropathic animals. The effects of selective loss of nociceptor function will be investigated using the neurotoxin, capsaicin (Sp. Aim 3), and selective depletion of LTMs will be examined by use of mice mutant for specific neurotrophic factors (Sp. Aim 4). The final two specific aims focus on the mechanisms of increased excitability of the spinal dorsal horn that develops following a nerve injury. This dorsal horn sensitization could be due to either an increase in excitatory mechanisms or a decrease in inhibitory mechanisms. During the coming grant period, changes in excitatory mechanisms will be explored by investigating the modulatory effects of neurokinin (NK) receptor systems on nociceptive transmission in the spinal cord (Sp. Aim 5). Changes in inhibitory mechanisms will be explored by investigating the modulatory effects of opioid receptor systems (Sp. Aim 6). Pharmacological and neurophysiological studies with selective NK antagonists will be used to determine if the NK receptors are upregulated in neuropathic pain. In addition, pain behavior and dorsal horn physiology will be examined in NK-1 receptor and mu-opioid receptor knockout mice. The results of these studies should provide new insights into the peripheral and central mechanisms of neuropathic pain and may lead to novel diagnostic and therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post-Amp Pain
-
批准号:7044588
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2003
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6354092
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2000
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6202103
-
项目类别:
-
资助金额:$26.21万
-
财政年份:1999
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6108824
-
项目类别:
-
资助金额:$26.21万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6297539
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
TREATMENT OF NEUROPATHIC PAIN
-
批准号:6112491
-
项目类别:
-
资助金额:$25.35万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6297552
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6218263
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6218286
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6114352
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6114375
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:SRINIVASA N. RAJA
-
依托单位:
TREATMENT OF NEUROPATHIC PAIN
-
批准号:6243789
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
-
批准号:6241347
-
项目类别:
-
资助金额:$26.24万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
POST HERPETIC NEURALGIA/AMITRYPTILINE VS MORPHINE IN PATIENT MANAGEMENT
-
批准号:6275610
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
TRICYCLIC ANTIDEPRESSANTS AND OPIOIDS IN POSTHERPETIC NEURALGIA MANAGEMENT
-
批准号:6245387
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
RESPONSE TO IV LIDOCAINE PREDICT FAVORABLE RESPONSE TO ORAL MEXILETIE
-
批准号:6275587
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:SRINIVASA N. RAJA
-
依托单位:
INJURY INDUCED PAIN--CHEMICAL MODULATION OF NOCICEPTORS
-
批准号:2891727
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
INJURY-INDUCES PAIN-- CHEMICAL MODULATION OF NOCICEPTORS
-
批准号:6539673
-
项目类别:
-
资助金额:$32.7万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
Injury-Induced Pain: Chemical Modulation of Nociceptors
-
批准号:7778283
-
项目类别:
-
资助金额:$30.54万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位:
Injury-Induced Pain: Chemical Modulation of Nociceptors
-
批准号:7388976
-
项目类别:
-
资助金额:$30.86万
-
财政年份:1989
-
负责人:SRINIVASA N. RAJA
-
依托单位: